Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Liver Diseases 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Blood Specimen Collection 2titanium silicide 1fluorocholine 1aumolertinib 1Sufentanil 1Sorafenib 1Ropivacaine 1Portasystemic Shunt, Transjugular Intrahepatic 1Microspheres 1Liver Transplantation 1Leucovorin 1Laparoscopy 1Ketorolac 1High-Energy Shock Waves 1Formyltetrahydrofolates 1Fluorodeoxyglucose F18 1Everolimus 1Analgesia, Epidural 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Liver Diseases × fluorocholine × Clear all
NCT02074202 2014-02-28

To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma

National Taiwan University Hospital

Phase 3 Unknown
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡